14 February 2020 in Animal Genetics
18 October 2021 in PLOS ONE
The intestinal microbiome plays a central role in human health and disease. While its composition is relatively stable throughout adulthood, the microbial balance starts to decrease in later life stages. Thus, in order to maintain a good quality of life, including the prevention of age-associated diseases in the elderly, it is important to understand the dynamics of the intestinal microbiome. In this study, stool samples of 278 participants were sequenced by whole metagenome shotgun sequencing and their taxonomic and functional profiles characterized. The two age groups, below65 and above65, could be separated based on taxonomic and associated functional features using Multivariate Association of Linear Models. In a second approach, through machine learning, biomarkers connecting the intestinal microbiome with age were identified. These results reflect the importance to select age-matched study groups for unbiased metagenomic data analysis and the possibility to generate robust data by applying independent algorithms for data analysis. Furthermore, since the intestinal microbiome can be modulated by antibiotics and probiotics, the data of this study may have implications on preventive strategies of age-associated degradation processes and diseases by microbiome-altering interventions.
24 July 2010 in Conservation Genetics Resources
31 May 2024 in Science Advances
Translation of mRNAs is a fundamental process that occurs in all cell types of multicellular organisms. Conventionally, it has been considered a default step in gene expression, lacking specific regulation. However, recent studies have documented that certain mRNAs exhibit cell type–specific translation. Despite this, it remains unclear whether global translation is controlled in a cell type–specific manner. By using human cell lines and mouse models, we found that deletion of the ribosome-associated protein ribonuclease inhibitor 1 (RNH1) decreases global translation selectively in hematopoietic-origin cells but not in the non–hematopoietic-origin cells. RNH1-mediated cell type–specific translation is mechanistically linked to angiogenin-induced ribosomal biogenesis. Collectively, this study unravels the existence of cell type–specific global translation regulators and highlights the complex translation regulation in vertebrates.
16 August 2022 in bioRxiv
T helper 9 cells (T H 9) are key drivers of allergic tissue inflammation. They are characterized by the expression of type 2 cytokines, such as IL-9 and IL-13, and the peroxisome proliferator-activated receptor gamma (PPAR-γ) transcription factor. However, the functional role of PPAR-γ in human T H 9 cells remains unknown. Here, we demonstrate that PPAR-γ drives activation-induced glycolysis, which, in turn, specifically promotes the expression of IL-9, but not IL-13, in an mTORC1-dependent manner. In vitro and ex vivo experiments on skin samples of allergic contact dermatitis showed that the PPAR-γ-mTORC1-IL-9 pathway was active in T H 9 cells in human skin inflammation. Additionally, we found that tissue glucose levels were dynamically regulated in acute allergic skin inflammation, suggesting that in situ glucose availability is linked to distinct immunological signals in vivo. Furthermore, paracrine IL-9 induced the lactate transporter MCT1 in IL-9R + T H cells, where it increased aerobic glycolysis and proliferative capacity. Taken together, our findings delineate a hitherto unknown relationship between PPAR-γ-dependent glucose metabolism and the pathogenic effector function of human T H 9 cells. Graphical
26 November 2021 in Zeitschrift für Geburtshilfe und Neonatologie
Introduction Hypertensive disorders in pregnancy (HDP), including preeclampsia (PE) and gestational or chronic hypertension (HT), are associated with an increased risk for long-term cardiovascular disorders for both mother and infant[1]. There is increased evidence that HDP are vascular disorders with a shared predisposition. Specifically, HDP appear to induce epigenetic changes. These are changes in DNA methylation profiles in CpG dinucleotides that can occur in the fetal/placental and maternal compartment[2]. Although cell-free DNA (cfDNA) assessments have become an important part of prenatal care, the use of cfDNA methylation patterns to detect HDP in early pregnancy is still largely unexplored. Hence, we aimed to test cardiovascular predisposition for HDP using cfDNA methylation profiles. Material/Methods Samples from the Liquid Biobank Bern previously collected at our clinic were assigned to 3 different cohorts with 5 patients per group: PE group (low risk for PE but subsequent PE), HT group (chronic hypertension with high risk for PE but no subsequent PE) and Control group (low risk for PE and no subsequent PE). Risk stratification for PE was based on the FMF screening algorithm in the first trimester[3]. We performed cfDNA extraction and whole-genome cfDNA methylation sequencing on our first trimester samples. Furthermore, we assessed unbiased determination of the tissue origins of cfDNA using deconvolution and identified differentially methylated regions (DMRs) and annotated genes. DMRs are regions in the genome where different DNA methylation patterns can point to specific diseases. We used Student's t tests and one-way analysis of variance and Holm-Sidak test. We considered p<0.05 to be statistically significant. Results Clinical characteristics at inclusion in early pregnancy of our three cohorts differed only in FMF risk stratification for PE and incidence of chronic hypertension. Global cfDNA methylation changes and potential cfDNA methylation origin point towards a homogenous PE/HT group. We detected 86 DMRs in PE/HT (75 genes) compared to PE/Ctr (DMRs: 139 and 75 genes) and HT/Ctr (DMRs: 140 and 74 genes) groups. Analysis of specific genes point towards an association with cardiovascular disorders. Furthermore, placental methylation origin of cfDNA appears to be low. Discussion The cfDNA methylation profile in the first trimester supports the pivotal role of the cardiovascular system in HDP pathogenesis. Using cfDNA methylation profiles, we envision a personalized approach crucial to prophylaxis and treatment of HPD and chronic cardiovascular diseases in pregnancy and beyond. Publication Date: 26 November 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany